• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Publication relating to transparency notifications

    5/30/25 4:30:00 PM ET
    $NYXH
    Medical/Dental Instruments
    Health Care
    Get the next $NYXH alert in real time by email

                    

    REGULATED INFORMATION

    Publication relating to transparency notifications

    Mont-Saint-Guibert (Belgium), May 30, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.

    Vestal Point Capital

    On May 27, 2025, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting rights. Based on the notification, Vestal Point Capital holds 1,809,843 voting rights, representing 4.84% of the total number of voting rights on May 21, 2025 (37,427,265).

    The notification dated May 27, 2025 contains the following information:

    • Reason for the notification: acquisition or disposal of voting securities or voting rights
    • Notification by: a parent undertaking or a controlling person
    • Persons subject to the notification requirement:
      • Vestal Point Capital, LLC (with address at 632 Broadway, Suite 602, New York, NY 10012, USA)
      • Vestal Point Capital, LP (with address at 632 Broadway, Suite 602, New York, NY 10012, USA)
      • Ryan Wilder (with address at 632 Broadway, Suite 602, New York, NY 10012, USA)
    • Date on which the threshold was crossed: May 21, 2025
    • Threshold that is crossed: 5%
    • Denominator: 37,427,265
    • Notified details:
    A) Voting rightsPrevious notificationAfter the transaction
     # of voting rights# of voting rights% of voting rights
    Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
    Ryan Wilder0000.00%0.00%
    Vestal Point Capital, LLC0000.00%0.00%
    Vestal Point Capital, LP3,000,6881,809,843 04.84%0.00%
    Subtotal3,000,6881,809,843  4.84% 
     TOTAL1,809,843 04.84%0.00%
    • Full chain of controlled undertakings through which the holding is effectively held: Vestal Point Capital, LP (investment manager) is controlled by Vestal Point Capital, LLC (general partner). Vestal Point Capital, LLC is controlled by Mr. Ryan Wilder (managing member).
    • Additional information: Vestal Point Capital, LP is the investment management company that can exercise the voting rights at its discretion, in the absence of specific instruction.

    *

    * *

    Contact:

    Nyxoah

    John Landry, CFO

    [email protected]

    Attachment

    • 2025 05 30 PR Transparency notifications 2025 05 (Vestal Point) (ENG)


    Primary Logo

    Get the next $NYXH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NYXH

    DatePrice TargetRatingAnalyst
    7/31/2023Buy
    H.C. Wainwright
    7/19/2023Neutral
    Robert W. Baird
    4/21/2022$30.00Outperform
    Oppenheimer
    4/6/2022$21.00Peer Perform
    Wolfe Research
    12/21/2021$47.00Overweight
    Cantor Fitzgerald
    7/28/2021$43.00Overweight
    Cantor Fitzgerald
    7/28/2021$40.00Overweight
    Piper Sandler
    7/27/2021$43.00Buy
    Stifel
    More analyst ratings